NEOGENE THERAPEUTICS
Neogene Therapeutics provides cancer patients with T cell therapies targeting mutated proteins called neo-antigens. The company is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells. Neogene's platform allows for the isolation of neo-antigen specific TCR genes from tumor biopsies that are routinely obtained from cancer patients during treatment. The tumor-infiltrating... lymphocytes (TIL) obtained by these tumor biopsies frequently express TCRs specific for mutated proteins found in cancer cells (neo-antigens). The company’s proprietary technology uses state-of-the-art DNA sequencing, DNA synthesis and genetic screening tools to identify such neo-antigen specific T cell receptor genes within tumor biopsies with high sensitivity, specificity and at scale.
NEOGENE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.neogene.com
Total Employee:
11+
Status:
Active
Total Funding:
125 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Pontifax
Pontifax investment in Series A - Neogene Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Neogene Therapeutics
Two River
Two River investment in Series A - Neogene Therapeutics
Jeito Capital
Jeito Capital investment in Series A - Neogene Therapeutics
Vida Ventures
Vida Ventures investment in Series A - Neogene Therapeutics
TPG
TPG investment in Series A - Neogene Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Neogene Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series A - Neogene Therapeutics
Key Employee Changes
Official Site Inspections
http://www.neogene.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.6 K
- Host name: ec2-54-157-108-158.compute-1.amazonaws.com
- IP address: 54.157.108.158
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Neogene Therapeutics"
Neogene Therapeutics
Neogene Therapeutics is now a part of the AstraZeneca Group. Visit AstraZeneca.com. AstraZeneca.com ...See details»
AstraZeneca to acquire Neogene Therapeutics,
Nov 29, 2022 Neogene was founded by Carsten Linnemann, PhD, Chief Executive Officer of Neogene, and Ton Schumacher, PhD, Principal Investigator at the Netherlands Cancer …See details»
Neogene Therapeutics 2025 Company Profile: …
Neogene Therapeutics is headquartered in Santa Monica, CA. What is the size of Neogene Therapeutics? Neogene Therapeutics has 120 total employees. …See details»
AstraZeneca to Acquire Neogene Therapeutics ... - Business Wire
Nov 29, 2022 Neogene was founded by cell therapy veterans Carsten Linnemann, PhD, Chief Executive Officer of Neogene, and Ton Schumacher, PhD, Chairman of Neogene’s Scientific …See details»
Neogene Therapeutics - Crunchbase Company Profile …
Neogene Therapeutics provides cancer patients with T cell therapies targeting mutated proteins called neo-antigens. The company is developing novel …See details»
AstraZeneca to acquire Neogene Therapeutics, accelerating …
Nov 29, 2022 Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours. AstraZeneca today announced an agreement …See details»
Org Chart Neogene Therapeutics - The Official Board
Organizational Chart of Neogene Therapeutics. Neogene Therapeutics www.neogene.com. has 9 executives - and belongs to AstraZeneca US +1 212 871 7920; Add an executive. Neogene …See details»
AstraZeneca enters $320m deal to acquire Neogene
Nov 29, 2022 The pipeline of Neogene comprises completely individualised TCR therapies and TCR therapies which act on shared neoantigens, including mutated KRAS and mutated TP53. The latest development comes after the company …See details»
Neogene's Focus On Off-The-Shelf TCR Therapies
Oct 31, 2024 Organization At-A-Glance Neogene Therapeutics is a global, clinical-stage biotechnology company that specializes in developing next-generation T-cell receptor therapies (TCR-Ts) for cancer treatment. Their …See details»
Neogene Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neogene Therapeutics, Inc. of Santa Monica, CA. Get the latest business insights from Dun & Bradstreet.See details»
Acquisition of Neogene Therapeutics completed
Jan 16, 2023 Neogene was founded by Carsten Linnemann, PhD, Chief Executive Officer of Neogene, and Ton Schumacher, PhD, Principal Investigator at the Netherlands Cancer Institute, Oncode Institute in partnership with Two …See details»
Neogene Therapeutics B.V. - bcfcareer.nl
Neogene Therapeutics is a pre-clinical stage biotechnology company aiming to change the paradigm of treatment for solid cancers. Our mission is to provide cancer patients with T cell …See details»
Neogene Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Neogene Therapeutics is a company that specializes in developing T cell therapies for cancer patients. These therapies target mutated proteins known as neo-antigens, which are unique to …See details»
Acquisition of Neogene Therapeutics completed
Jan 17, 2023 Neogene was founded by Carsten Linnemann, PhD, Chief Executive Officer of Neogene, and Ton Schumacher, PhD, Principal Investigator at the Netherlands Cancer …See details»
Neogene Picks Cell Therapy Hub Santa Monica as U.S. Headquarters
Jun 22, 2021 Neogene has leased 38,000 square feet in two Santa Monica buildings. Brent Pfeiffenberger will lead the U.S. operations and currently has 20 local employees. ... He …See details»
Neogene Therapeutics Inc. - life-sciences-europe.com
Jan 1, 2018 Neogene was founded by Carsten Linnemann, PhD, Chief Executive Officer of Neogene, and Ton Schumacher, PhD, Principal Investigator at the Netherlands Cancer …See details»
Neogene Therapeutics - Craft
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. It provides cancer patients with therapies …See details»
Biotech Company Neogene Therapeutics Selects Santa Monica as …
Jun 20, 2021 Amsterdam-based Neogene Therapeutics Inc., which was founded in 2018, announced May 24 that it has leased 38,000 square feet of space in two buildings in Santa …See details»
Neogene Therapeutics Raises $110 Million Series A Financing to …
Sep 14, 2020 Neogene’s novel approach intends to deliver a tailored set of TCR genes for each individual patient, which will be engineered into patient-derived T cells directing them towards …See details»
Neogene Picks Cell Therapy Hub Santa Monica as U.S. Headquarters
Jun 21, 2021 Amsterdam-based Neogene Therapeutics, which launched in 2018, is setting up its U.S. headquarters in Santa Monica, California. The company has the backing of biotech guru …See details»